BYSL and osteosarcoma: Additionally, miR-378a-3p can inhibit EMT and invasion by directly targeting BYSL. The miR-378a-3p/BYSL axis may play a role in osteosarcoma, and the cilinical significance of miR-378a-3p in osteosarcoma patients should be explored in the future.